268 related articles for article (PubMed ID: 10852764)
21. Relationship among pulmonary function, bronchial reactivity, and exhaled nitric oxide in a large group of asthmatic patients.
Langley SJ; Goldthorpe S; Custovic A; Woodcock A
Ann Allergy Asthma Immunol; 2003 Oct; 91(4):398-404. PubMed ID: 14582820
[TBL] [Abstract][Full Text] [Related]
22. Risk factors for near-fatal asthma.
Gelb AF; Schein A; Nussbaum E; Shinar CM; Aelony Y; Aharonian H; Zamel N
Chest; 2004 Oct; 126(4):1138-46. PubMed ID: 15486375
[TBL] [Abstract][Full Text] [Related]
23. Methacholine challenge test: diagnostic characteristics in asthmatic patients receiving controller medications.
Sumino K; Sugar EA; Irvin CG; Kaminsky DA; Shade D; Wei CY; Holbrook JT; Wise RA; Castro M;
J Allergy Clin Immunol; 2012 Jul; 130(1):69-75.e6. PubMed ID: 22465214
[TBL] [Abstract][Full Text] [Related]
24. Perception of bronchoconstriction: a complementary disease marker in children with asthma.
Nuijsink M; Hop WC; Jongste JC; Sterk PJ; Duiverman AE;
J Asthma; 2013 Aug; 50(6):560-4. PubMed ID: 23672570
[TBL] [Abstract][Full Text] [Related]
25. [Airway inflammation and peripheral airway function in asthmatic patients with different control levels].
Pan Y; Huang KW; Ye Q; Liu XS; Wu BM; Zhang J; Chang XH; Lu Y; Wang C
Zhonghua Jie He He Hu Xi Za Zhi; 2009 Sep; 32(9):679-84. PubMed ID: 20079282
[TBL] [Abstract][Full Text] [Related]
26. Association between asthma control and bronchial hyperresponsiveness and airways inflammation: a cross-sectional study in daily practice.
Quaedvlieg V; Sele J; Henket M; Louis R
Clin Exp Allergy; 2009 Dec; 39(12):1822-9. PubMed ID: 19817755
[TBL] [Abstract][Full Text] [Related]
27. Peripheral ventilation heterogeneity determines the extent of bronchoconstriction in asthma.
Farrow CE; Salome CM; Harris BE; Bailey DL; Berend N; King GG
J Appl Physiol (1985); 2017 Nov; 123(5):1188-1194. PubMed ID: 28798203
[TBL] [Abstract][Full Text] [Related]
28. Impaired perception of dyspnea in patients with severe asthma. Relation to sputum eosinophils.
Veen JC; Smits HH; Ravensberg AJ; Hiemstra PS; Sterk PJ; Bel EH
Am J Respir Crit Care Med; 1998 Oct; 158(4):1134-41. PubMed ID: 9769272
[TBL] [Abstract][Full Text] [Related]
29. Long-term follow-up of pulmonary function in patients with nasal polyposis.
Lamblin C; Brichet A; Perez T; Darras J; Tonnel AB; Wallaert B
Am J Respir Crit Care Med; 2000 Feb; 161(2 Pt 1):406-13. PubMed ID: 10673178
[TBL] [Abstract][Full Text] [Related]
30. Add-on montelukast to inhaled corticosteroids protects against excessive airway narrowing.
Ulrik CS; Diamant Z
Clin Exp Allergy; 2010 Apr; 40(4):576-81. PubMed ID: 20128823
[TBL] [Abstract][Full Text] [Related]
31. Adolescents in clinical remission of atopic asthma have elevated exhaled nitric oxide levels and bronchial hyperresponsiveness.
van Den Toorn LM; Prins JB; Overbeek SE; Hoogsteden HC; de Jongste JC
Am J Respir Crit Care Med; 2000 Sep; 162(3 Pt 1):953-7. PubMed ID: 10988112
[TBL] [Abstract][Full Text] [Related]
32. Determinants of airway responsiveness to adenosine 5'-monophosphate in school-age children with asthma.
Bakirtas A; Turktas I
Pediatr Pulmonol; 2006 Jun; 41(6):515-21. PubMed ID: 16617445
[TBL] [Abstract][Full Text] [Related]
33. Time-dependent effects of inhaled corticosteroids on lung function, bronchial hyperresponsiveness, and airway inflammation in asthma.
Mehta V; Stokes JR; Berro A; Romero FA; Casale TB
Ann Allergy Asthma Immunol; 2009 Jul; 103(1):31-7. PubMed ID: 19663124
[TBL] [Abstract][Full Text] [Related]
34. Airway hyperresponsiveness in asthma. Not just a problem of smooth muscle relaxation with inspiration.
Burns GP; Gibson GJ
Am J Respir Crit Care Med; 1998 Jul; 158(1):203-6. PubMed ID: 9655730
[TBL] [Abstract][Full Text] [Related]
35. Airway responsiveness as a direct factor contributing to the dyspnoea perception in asthma.
Koh YI; Choi IS; Lim H
Respir Med; 2001 Jun; 95(6):464-70. PubMed ID: 11421503
[TBL] [Abstract][Full Text] [Related]
36. Relationships of methacholine and adenosine monophosphate responsiveness with serum vascular endothelial growth factor in children with asthma.
Yoo Y; Choi IS; Byeon JH; Lee SM; La KS; Choi BM; Park SH; Choung JT
Ann Allergy Asthma Immunol; 2010 Jan; 104(1):36-41. PubMed ID: 20143643
[TBL] [Abstract][Full Text] [Related]
37. Early protective effects of tiotropium bromide in patients with airways hyperresponsiveness.
Terzano C; Petroianni A; Ricci A; D'Antoni L; Allegra L
Eur Rev Med Pharmacol Sci; 2004; 8(6):259-64. PubMed ID: 15745385
[TBL] [Abstract][Full Text] [Related]
38. Effect of an inhaled thromboxane mimetic (U46619) on airway function in human subjects.
Jones GL; Saroea HG; Watson RM; O'Byrne PM
Am Rev Respir Dis; 1992 Jun; 145(6):1270-4. PubMed ID: 1595990
[TBL] [Abstract][Full Text] [Related]
39. The safety and efficacy of inhaled dry powder mannitol as a bronchial provocation test for airway hyperresponsiveness: a phase 3 comparison study with hypertonic (4.5%) saline.
Brannan JD; Anderson SD; Perry CP; Freed-Martens R; Lassig AR; Charlton B;
Respir Res; 2005 Dec; 6(1):144. PubMed ID: 16336673
[TBL] [Abstract][Full Text] [Related]
40. Questionnaire responses that predict airway response to hypertonic saline.
Leuppi JD; Anderson SD; Brannan JD; Belousova E; Reddel HK; Rodwell LT
Respiration; 2005; 72(1):52-60. PubMed ID: 15753635
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
